Unnatural Selection
By Ralph Brave,
Baltimore City Paper
| 06. 21. 2000
Any day now, the Rockville-based Celera Genomics Group and
the National Institutes of Health will announce that they have achieved a feat
unique in all of history, one that will alter the destiny of all humanity for
all time to come: the decoding of the entire human genome, the 3 billion or so
units of DNA in every cell in the human body--the code of human life in all its
variety.
The effort of thousands of people and the expenditure of billions of dollars
have gone into the making of this epochal moment, but when it occurs it will
belong above all others to James Watson--first director of the federal
government’s Human Genome Project, the pioneering biochemist whose work
uncovering the double-helix structure of DNA made the project possible. Thus it
is only fitting that Watson provide the invocation for any effort to understand
the meaning of this miracle. Here, then, is James Watson on the awesome
responsibility of assuming stewardship over the sacred stuff of life itself:
“Evolution can be just damn cruel, and to say that we’ve got...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...